137 related articles for article (PubMed ID: 9673748)
1. Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF).
Florin TH; Roberts RK; Watson MR; Radford-Smith GL
Aust N Z J Med; 1998 Jun; 28(3):344-5. PubMed ID: 9673748
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.
Smith MR; Cooper SC
J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
Palaniappan S; Ford AC; Greer D; Everett SM; Chalmers DM; Axon AT; Hamlin PJ
Inflamm Bowel Dis; 2007 Dec; 13(12):1488-92. PubMed ID: 17924566
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in refractory inflammatory bowel disease.
Ford AC; Towler RJ; Moayyedi P; Chalmers DM; Axon AT
Aliment Pharmacol Ther; 2003 Jun; 17(11):1365-9. PubMed ID: 12786630
[TBL] [Abstract][Full Text] [Related]
5. Use of mycophenolate mofetil in inflammatory bowel disease.
Tan T; Lawrance IC
World J Gastroenterol; 2009 Apr; 15(13):1594-9. PubMed ID: 19340901
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
Fellermann K; Steffen M; Stein J; Raedler A; Hämling J; Ludwig D; Loeschke K; Stange EF
Aliment Pharmacol Ther; 2000 Feb; 14(2):171-6. PubMed ID: 10651657
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease workshop. Vail, Colorado, March 22 and 23, 1998. Maintenance therapy in IBD.
Tremaine WJ
Inflamm Bowel Dis; 1998 Nov; 4(4):292-5; discussion 295-301. PubMed ID: 9836082
[No Abstract] [Full Text] [Related]
9. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
Present DH
Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil for Crohn's disease?
Lowry PW; Sandborn WJ; Lipsky JJ
Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
[No Abstract] [Full Text] [Related]
11. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.
Salvadori M; Bertoni E; Budde K; Holzer H; Civati G; Lien B; Arns W
Transplant Proc; 2010 May; 42(4):1325-8. PubMed ID: 20534293
[TBL] [Abstract][Full Text] [Related]
12. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.
Hernández-Camba A; Arranz L; Vera I; Carpio D; Calafat M; Lucendo AJ; Taxonera C; Marín S; Garcia MJ; Marín GS; Rodríguez ES; Carbajo AY; De Castro ML; Iborra M; Martin-Cardona A; Rodríguez-Lago I; Busquets D; Bertoletti F; Ausín MS; Tardillo C; Malaves JH; Bujanda L; Castaño A; Domènech E; Ramos L; ;
Dig Liver Dis; 2022 May; 54(5):635-641. PubMed ID: 34862115
[TBL] [Abstract][Full Text] [Related]
13. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM; Smoyer WE; Bunchman TE; Flynn JT; Kershaw DB
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[TBL] [Abstract][Full Text] [Related]
14. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
Seibold F; Wagner AC; Göke B
Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
[TBL] [Abstract][Full Text] [Related]
15. Failure of mycophenolate mofetil therapy in primary refractory nephrotic syndrome.
Baglio V; Pecci G; Gangemi C; Barresi G; Morabito S; Pierucci A
J Nephrol; 2006; 19(6):819-24. PubMed ID: 17173257
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of inflammatory bowel disease.
Shanahan F; Targan S
Annu Rev Med; 1992; 43():125-33. PubMed ID: 1580577
[TBL] [Abstract][Full Text] [Related]
18. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
Hellström PM; Schmidt D; Karlén P
Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
[No Abstract] [Full Text] [Related]
19. Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.
Skelly MM; Logan RF; Jenkins D; Mahida YR; Hawkey CJ
Inflamm Bowel Dis; 2002 Mar; 8(2):93-7. PubMed ID: 11854606
[TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
Hermida-Rodriguez C; Cantero Perona J; Garcia-Valriberas R; Pajares Garcia JM; Mate-Jimenez J
Hepatogastroenterology; 1999; 46(28):2265-8. PubMed ID: 10521978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
